Renee D. Gala, President & CEO at Jazz Pharmaceuticals plc (JAZZ), sold 2,000 shares at $236.40 ($473K) on 2026-10-06, disclosed to the SEC on 2026-10-07.
Scheduled sale ($473k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| JAZZ | SELL | 2022-12-22 | $422K | — | Filing → |
| TBPH | SELL | 2018-08-16 | $2.3M | — | Filing → |
| TBPH | SELL | 2018-05-22 | $243K | — | Filing → |